# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-21-262161
Filing Date
2021-08-31
Accepted
2021-08-31 17:03:47
Documents
46
Period of Report
2021-08-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d189880d8k.htm iXBRL | 8-K | 26628
2 | EX-99.1 | d189880dex991.htm | EX-99.1 | 37378
6 | GRAPHIC | g189880ex99_1s10g1.jpg | GRAPHIC | 373504
7 | GRAPHIC | g189880ex99_1s11g1.jpg | GRAPHIC | 329206
8 | GRAPHIC | g189880ex99_1s12g1.jpg | GRAPHIC | 358518
9 | GRAPHIC | g189880ex99_1s13g1.jpg | GRAPHIC | 360027
10 | GRAPHIC | g189880ex99_1s14g1.jpg | GRAPHIC | 367455
11 | GRAPHIC | g189880ex99_1s15g1.jpg | GRAPHIC | 324385
12 | GRAPHIC | g189880ex99_1s16g1.jpg | GRAPHIC | 102564
13 | GRAPHIC | g189880ex99_1s17g1.jpg | GRAPHIC | 387404
14 | GRAPHIC | g189880ex99_1s18g1.jpg | GRAPHIC | 412568
15 | GRAPHIC | g189880ex99_1s19g1.jpg | GRAPHIC | 222956
16 | GRAPHIC | g189880ex99_1s1g1.jpg | GRAPHIC | 101378
17 | GRAPHIC | g189880ex99_1s20g1.jpg | GRAPHIC | 282477
18 | GRAPHIC | g189880ex99_1s21g1.jpg | GRAPHIC | 235151
19 | GRAPHIC | g189880ex99_1s22g1.jpg | GRAPHIC | 340487
20 | GRAPHIC | g189880ex99_1s23g1.jpg | GRAPHIC | 324549
21 | GRAPHIC | g189880ex99_1s24g1.jpg | GRAPHIC | 285669
22 | GRAPHIC | g189880ex99_1s25g1.jpg | GRAPHIC | 192390
23 | GRAPHIC | g189880ex99_1s26g1.jpg | GRAPHIC | 88833
24 | GRAPHIC | g189880ex99_1s27g1.jpg | GRAPHIC | 172374
25 | GRAPHIC | g189880ex99_1s28g1.jpg | GRAPHIC | 216764
26 | GRAPHIC | g189880ex99_1s29g1.jpg | GRAPHIC | 282916
27 | GRAPHIC | g189880ex99_1s2g1.jpg | GRAPHIC | 518006
28 | GRAPHIC | g189880ex99_1s30g1.jpg | GRAPHIC | 303574
29 | GRAPHIC | g189880ex99_1s31g1.jpg | GRAPHIC | 204938
30 | GRAPHIC | g189880ex99_1s32g1.jpg | GRAPHIC | 317780
31 | GRAPHIC | g189880ex99_1s33g1.jpg | GRAPHIC | 367405
32 | GRAPHIC | g189880ex99_1s3g1.jpg | GRAPHIC | 366437
33 | GRAPHIC | g189880ex99_1s4g1.jpg | GRAPHIC | 282490
34 | GRAPHIC | g189880ex99_1s5g1.jpg | GRAPHIC | 326628
35 | GRAPHIC | g189880ex99_1s6g1.jpg | GRAPHIC | 381738
36 | GRAPHIC | g189880ex99_1s7g1.jpg | GRAPHIC | 337132
37 | GRAPHIC | g189880ex99_1s8g1.jpg | GRAPHIC | 221545
38 | GRAPHIC | g189880ex99_1s9g1.jpg | GRAPHIC | 106678
| Complete submission text file | 0001193125-21-262161.txt |  | 13285191

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | abos-20210831.xsd | EX-101.SCH | 2900
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | abos-20210831_lab.xml | EX-101.LAB | 18122
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | abos-20210831_pre.xml | EX-101.PRE | 11410
39 | EXTRACTED XBRL INSTANCE DOCUMENT | d189880d8k_htm.xml | XML | 3347

Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40551 | Film No.: 211227660
SIC: 2836 Biological Products, (No Diagnostic Substances)